HHT
Clinical trials for HHT explained in plain language.
Never miss a new study
Get alerted when new HHT trials appear
Sign up with your email to follow new studies for HHT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can a cancer drug calm the nosebleeds of a rare bleeding disorder?
Symptom relief Recruiting nowHereditary hemorrhagic telangiectasia (HHT) causes tangled blood vessels that lead to frequent, hard-to-stop nosebleeds and low hemoglobin. Researchers are testing whether intravenous bevacizumab, given once or twice a year after nasal electrocoagulation, reduces nosebleed severi…
Matched conditions: HHT
Phase 2 • Sponsor: Second Affiliated Hospital, Zhejiang University, School of Medicine • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC
-
New registry aims to unlock secrets of rare diseases
Knowledge-focused Recruiting nowThis study is creating a large database to collect information on people with rare diseases like amyloidosis, sarcoidosis, and Gaucher disease. Researchers will track patients' health over time, including their symptoms, treatments, and outcomes. The goal is to improve diagnosis …
Matched conditions: HHT
Sponsor: Hospital Italiano de Buenos Aires • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:11 UTC